J.C. Penney Offers A ‘Poison Pill’ Rights Agreement, Citi Says Sell – ValueWalk Premium

J.C. Penney Offers A ‘Poison Pill’ Rights Agreement, Citi Says Sell

J.C. Penney Company, Inc. (NYSE:JCP) announced a shareholder rights program yesterday that seeks to protect the company from a takeover attempt. A new report on the company, out of Citigroup Inc (NYSE:C), takes a look at the likely effect of the new scheme. Unfortunately for shareholders, the analyses don't see many positives in the poison pill.

The analyst . . .

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk